Markus Renschler, Sr. VP, Oncology Clinical Dev at Pharmacyclics, holds 1.39K shares in Pharmacyclics (Ticker: PCYC), holds 1.10M shares in Cyteir Therapeutics (Ticker: CYT). Most recently, Markus Renschler ― shares of Pharmacyclics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Markus Renschler?
The percentage of profitable transactions made by Markus Renschler is ―.
What is the average return per transaction made by Markus Renschler?
The average return per transaction made by Markus Renschler is ―.
What stocks does Markus Renschler hold?
Markus Renschler holds: PCYC, CYT stocks.
What was Markus Renschler’s latest transaction?
Markus Renschler latest transaction was an Uninformative Buy of ―.
What was Markus Renschler's most profitable transaction?
Markus Renschler’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Markus Renschler's role in Pharmacyclics?
Markus Renschler's role in Pharmacyclics is Sr. VP, Oncology Clinical Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.